GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
N

NextCell Pharma NXTCL.ST · SEK

Health Care · Nasdaq Stockholm · 🇸🇪 Sweden

Compare

0.25

-9.95%

Close of 9 Nov 2026, in SEK

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

NextCell Pharma annual report

Figures from our data supplier

We don't hold this company's report document. It publishes it on its own website.

Company website ↗

Five-year highlights

In SEK.

FY2025FY2024FY2023FY2022FY2021
RevenueSEK 10.9mSEK 10.7mSEK 10.1mSEK 5.6mSEK 3.9m
Operating income−SEK 35.9m−SEK 43.2m−SEK 41.0m−SEK 35.0m−SEK 24.8m
Net income−SEK 35.1m−SEK 42.0m−SEK 39.8m−SEK 34.1m−SEK 24.6m
Free cash flow−SEK 43.0m−SEK 37.9m−SEK 47.9m−SEK 40.9m−SEK 26.3m
Total assetsSEK 76.7mSEK 81.3mSEK 88.8mSEK 124.7mSEK 155.6m
Shareholders' equitySEK 66.4mSEK 67.6mSEK 75.7mSEK 115.5mSEK 150.1m

Sources and methodology

Data on this tab
SEC EDGAR and our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.